Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
2023年10月26日 - 8:00PM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose
mission is to develop medicines that meaningfully improve and
extend the lives of patients facing deadly diseases, today
announced that it will host a live conference call and audio
webcast on Thursday, November 2, 2023 at 8:30 a.m. ET to report
financial results for the third quarter ended September 30, 2023,
and to provide a business overview.
To access the live conference call, please dial (646) 307-1963
(domestic) or (800) 715-9871 (international) at least five minutes
prior to the start time, and refer to conference ID 5615320. A live
audio webcast of the call will also be available on the Investors’
section of the Company's website, www.chimerix.com. An archived
webcast will be available on the Chimerix website approximately two
hours after the event.
About Chimerix
Chimerix is a biopharmaceutical company with a mission to
develop medicines that meaningfully improve and extend the lives of
patients facing deadly diseases. The Company’s most advanced
clinical-stage development program, ONC201, is in development for
H3 K27M-mutant glioma.
CONTACTS:
Michelle LaSpaluto919 972-7115ir@chimerix.com
Will O’ConnorStern Investor
Relations212-362-1200will@sternir.com
Chimerix (NASDAQ:CMRX)
過去 株価チャート
から 4 2024 まで 5 2024
Chimerix (NASDAQ:CMRX)
過去 株価チャート
から 5 2023 まで 5 2024